| http://www.w3.org/ns/prov#value | - I think, Frank, I guess the last point I would make and just sort of a general point for at least from our perspective and perhaps the industry's perspective is more visibility to what the DEA and the FDA would like us to do and clarity around objectives and clarity around the kinds of programs they would like us to be moving toward would help move this needle forward.
|
